Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06295588 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing
    • Site details revised
    v10
  2. Primary completion date: Apr 15, 2026 to Dec 31, 2026
    • Start date: Jun 26, 2025 to Jul 26, 2025
    • Enrollment target: 30 to 40
    • Study completion date: Apr 15, 2026 to Jun 1, 2027
    v9
  3. Phase: Not applicable to Phase 2
    • Interventions: Fucoidan extracted from F. Vesiculosus (Dietary Supplement), Fucoidan extracted from U. Pinnatifida (Dietary Supplement) to Fucoidan extracted from F. Vesiculosus (Drug), Fucoidan extracted from U. Pinnatifida (Drug)
    v8
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 1, 2025 to Jun 26, 2025
    • Site details revised
    v7
  5. Start date: Mar 1, 2025 to May 1, 2025v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Dec 1, 2024 to Mar 1, 2025v5
  2. Primary and study completion dates: Apr 15, 2025 to Apr 15, 2026
    • Start date: Oct 1, 2024 to Dec 1, 2024
    v4
  3. Start date: Jul 15, 2024 to Oct 1, 2024v3
  4. Start date: Apr 15, 2024 to Jul 15, 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.
Trial Details
NCT Number NCT06295588
Lead Sponsor University of Rochester
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Fatigue, Inflammation
Related terms Fatigue, Inflammation
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov